Prevnar 20 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FBKA2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,240
Award facts
- Contract value 100% obligated
- $43,239.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $43,239.56 delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Prevnar 20 vaccine in 0.5ml syringes. The contract utilizes firm fixed price terms and is not set-aside designated, reflecting competitive award procedures. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
The Defense Logistics Agency Medical Supply Chain procures critical medical commodities through AmerisourceBergen to support military health systems globally, including supplies for the Defense Health Agency and U.S. Coast Guard. Prevnar 20 is a pneumococcal conjugate vaccine used for immunization purposes, and this order demonstrates DLA's ongoing pharmaceutical procurement needs. The contract maintains the ultimate completion date of September 19, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award is representative of AmerisourceBergen's established role as a critical federal vendor, consistently fulfilling competitive federal procurement requirements across a broad spectrum of medical products and therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FBKA2?
SPE2DB25FBKA2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FBKA2 worth?
The government has obligated $43,240 on SPE2DB25FBKA2.
Is contract SPE2DB25FBKA2 an order under another contract?
Yes. SPE2DB25FBKA2 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBKA2 competed?
The extent of competition for SPE2DB25FBKA2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award